Literature DB >> 15790648

Authors of TADS study reply to letter raising concerns.

John S March.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15790648      PMCID： PMC555670          DOI： 10.1136/bmj.330.7493.730-b

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

1.  Treatment for Adolescents With Depression Study (TADS): rationale, design, and methods.

Authors: 
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2003-05       Impact factor: 8.829

2.  Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.

Authors:  John March; Susan Silva; Stephen Petrycki; John Curry; Karen Wells; John Fairbank; Barbara Burns; Marisa Domino; Steven McNulty; Benedetto Vitiello; Joanne Severe
Journal:  JAMA       Date:  2004-08-18       Impact factor: 56.272
  2 in total
  2 in total

1.  Critical appraisal of adverse effects reporting in the 'Treatment for Adolescents With Depression Study (TADS)'.

Authors:  Tone Westergren; Sigrid Narum; Marianne Klemp
Journal:  BMJ Open       Date:  2019-03-15       Impact factor: 2.692

2.  Child/Adolescent Anxiety Multimodal Study (CAMS): rationale, design, and methods.

Authors:  Scott N Compton; John T Walkup; Anne Marie Albano; John C Piacentini; Boris Birmaher; Joel T Sherrill; Golda S Ginsburg; Moira A Rynn; James T McCracken; Bruce D Waslick; Satish Iyengar; Phillip C Kendall; John S March
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2010-01-05       Impact factor: 3.033
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.